The use of artificial intelligence in stereotactic ablative body radiotherapy for hepatocellular carcinoma
The integration of artificial intelligence (AI) into stereotactic ablative body radiotherapy (SABR) for hepatocellular carcinoma (HCC) is transforming the landscape of liver cancer treatment. SABR has emerged as a promising treatment option for patients with localized HCC, offering high local contro...
Saved in:
| Main Author: | Atsuto Katano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1576494/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center
by: Liang-Cheng Chen, et al.
Published: (2021-01-01) -
IMMUNE EFFECTS OF STEREOTACTIC ABLATIVE RADIATION THERAPY IN PATIENTS WITH MALIGNANT TUMORS: LITERATURE REVIEW
by: A. Yu. Zozulya, et al.
Published: (2020-10-01) -
Long‐Term Survival and Prognostic Factors of Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Hoang Dong Duc, et al.
Published: (2025-05-01) -
Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma
by: Song Z, et al.
Published: (2025-05-01) -
Ablative Therapies for Localized Primary Renal Cell Carcinoma
by: Muhammad Ali, et al.
Published: (2022-11-01)